Menu Search
Equities

Phytohealth Corp

4108:TAI

Phytohealth Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)18.05
  • Today's Change0.00 / 0.00%
  • Shares traded175.52k
  • 1 Year change-9.98%
  • Beta--
Data delayed at least 20 minutes, as of Sep 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in TWDIncome statement in TWDView more

Year on year Phytohealth Corp grew revenues 19.95% from 135.47m to 162.49m while net income improved from a loss of 79.41m to a smaller loss of 47.12m.
Gross margin40.89%
Net profit margin-59.90%
Operating margin-87.52%
Return on assets-4.22%
Return on equity-3.51%
Return on investment-5.07%
More ▼

Cash flow in TWDView more

In 2023, cash reserves at Phytohealth Corp fell by 37.70m. However, Cash Flow from Investing totalled 26.25m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 54.77m for operations while cash used for financing totalled 9.18m.
Cash flow per share-0.2328
Price/Cash flow per share--
Book value per share9.82
Tangible book value per share9.46
More ▼

Balance sheet in TWDView more

Phytohealth Corp uses little debt in its capital structure as supported by a debt to capital ratio of 1.05%.
Current ratio29.66
Quick ratio26.47
Total debt/total equity0.0123
Total debt/total capital0.0105
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.